Trivitron Healthcare launches new CT scanner ‘Terrene’

Trivitron Healthcare announced the launch of its state-of-the-art CT scanner, branded as “Terrene.” This technology is the first of its kind in India to receive approvals from the Bureau of Indian Standards (BIS), the Atomic Energy Regulatory Board (AERB) and Central Drugs Standard Control Organization (CDSCO), marking a significant milestone in the Indian healthcare industry.

The aim of Terrene CT scanner launch is to ensure accessibility of advanced technology in all the healthcare facilities. The scanner is manufactured at Trivitron’s ISO 9001 & ISO 13485 certified manufacturing facility located in Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam. This achievement reaffirms Trivitron’s dedication to excellence in medical technology and its mission to provide advanced and accessible healthcare solutions.

With advanced imaging technology and user-friendly features, the scanner offers enhanced image quality, reduced radiation dose, and streamlined workflow. Equipped with advanced software algorithms and an intuitive interface, the Terrene CT scanner empowers healthcare professionals to make accurate diagnoses and deliver optimal patient care with unmatched precision and efficiency.

With the growing demand for advanced diagnostic solutions, Trivitron’s Terrene CT scanner will play a major role in enhancing diagnostic accuracy and treatment efficacy. It will empower healthcare providers to deliver better patient care, ultimately improving health outcomes and advancing the quality of healthcare delivery in India.

Mr. Satyaki Banerjee,Executive Director and Group COO, Trivitron Healthcare, added, “The Terrene CT scanner sets a new benchmark in diagnostic imaging with its advanced technology and exceptional performance. This accomplishment not only highlights our technological prowess but also our commitment to improving healthcare delivery in India. We are excited to see the positive impact Terrene will have on patient outcomes and overall healthcare quality.”